Fondazione Italiana Linfomi
Commissione Studi Biologici e Bioinformatici
AI-CSBB is an initiative of the CSBB Commission aimed at building a collaborative research community capable of harnessing the power of artificial intelligence to extract crucial insights for understanding lymphoma — from disease onset to therapeutic response.
In the field of onco-hematology, the rise of multi-omics created an urgent need to integrate diverse data sources through a multidisciplinary approach. In response, the Fondazione Italiana Linfomi (FIL) has initiated a renewal process, establishing the Commission of Biological and Bioinformatics Studies (CSBB). This transformation established a centralized platform to integrate biological and clinical data, which leveraged the bridge between in-silico data-driven models and validation on “real-life” patient data. A first example has been implemented on Diffuse Large B-Cell Lymphoma (DLBCL). According to this, the FIL-CSBB created a repository encompassing recognized publicly available datasets to benchmark the development of analytical and artificial intelligence (AI) methods as a clinical hypothesis generator.
A first example has been implemented on Diffuse Large B-Cell Lymphoma (DLBCL). According to this, the AI-CSBB created a repository encompassing recognized publicly available datasets to benchmark the development of analytical and AI methods as a clinical hypothesis generator.